Annual Securities Report — FY2025
What Pharma Foods International Co.,Ltd. reported for the period from 2025-08-01 to 2026-07-31.
Filed 2026-10-23View the original on EDINET
How much it says
69Detailed
What moved here
28named for the first time
Its own wording
84terms
Which filing this is
31/ 31newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
In the fiscal year ended 31 July 2026, revenue declined year on year to ¥63,223 million, while operating profit increased to ¥2,632 million and net income attributable to owners of the parent was ¥1,988 million. The company also invested in R&D across its B2B, B2C and biomedical businesses and made capital investments totaling ¥4,027 million, including construction of a new plant to expand contract-manufacturing capacity for pharmaceuticals.
Komori's summary of this document, not the document's own words.69Detailed
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
80
Very detailed
61
Detailed
82
Very detailed
50
Typical
68
Detailed
55
Typical
100
Very detailed
60
Detailed
79
Very detailed
50
Typical
R&D spend0百万円Money spent making new things.
Cash left overNot disclosedThis document does not carry the figure.
Spent on equipment0百万円Plants, machines — things meant to last.
Employees625Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.